Bristol-Myers Squibb Company
Location
New Jersey
Founded
1887-04-10
Website
Risk Signals
10470 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Bristol-Myers Squibb Company
Live alerts from global media, monitored by Business Radar
2024-11-12 (yahoo.com)
3 Stocks Seeing Insider Buys: CNC, PFE, BMY
Investors can see insider buys as an overall net positive concerning the longer-term outlook for a stock.
Read more
2024-11-06 (marketbeat.com)
Bristol-Myers Squibb (NYSE:BMY) Sets New 52-Week High on Insider Buying Activity
Bristol-Myers Squibb (NYSE:BMY) Reaches New 52-Week High After Insider Buying Activity
Read more
2022-11-24 (medicaldialogues.in)
Apixaban patent Violation: HC reprimands BDR Pharma for callousness in implementing court order
New Delhi: Coming down heavily on BDR Pharmaceuticals International, the Delhi High Court has warned the Mumbai-based drug maker against its 'callous manner' regarding implementation of its orders...
Read more
2022-06-27 (bioprocessintl.com)
Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider
J&J and BMS have spoken of plans to increase supply of lentivirus as they continue to roll out their respective CAR-T therapies.
Read more
2022-06-27 (bioprocessintl.com)
Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider
J&J and BMS have spoken of plans to increase supply of lentivirus as they continue to roll out their respective CAR-T therapies.
Read more
2022-01-31 (marketwatch.com)
Bristol-myers Squibb (BMY) Trading Report
Jan 31, 2022 (Stock Traders Daily via COMTEX) -- Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to...
Read more
2021-11-16 (investingnews.com)
FILING DEADLINE--Kuznicki Law PLLC Announces Class... | INN
The securities litigation law firm of Kuznicki Law PLLC issues th
Read more
2019-12-18 (inquirer.com)
As prosecutor, Christie struck unusual deals
As the top federal prosecutor in New Jersey, Chris Christie struck an unusual deal with Bristol-Myers Squibb. In exchange for not charging the drug-making giant with securities fraud, Christie 's office would require it to fund a professorship at
Read more
2019-12-18 (inquirer.com)
As prosecutor, Christie struck unusual deals
As the top federal prosecutor in New Jersey, Chris Christie struck an unusual deal with Bristol-Myers Squibb. In exchange for not charging the drug-making giant with securities fraud, Christie 's office would require it to fund a professorship at
Read more
2019-12-18 (inquirer.com)
As prosecutor, Christie struck unusual deals
As the top federal prosecutor in New Jersey, Chris Christie struck an unusual deal with Bristol-Myers Squibb. In exchange for not charging the drug-making giant with securities fraud, Christie 's office would require it to fund a professorship at
Read more
2019-12-17 (inquirer.com)
Philly connection to guilty plea by Bristol-Myers Squibb executive on insider trading charges
Former Bristol-Myers Squibb executive Robert Ramnarine of East Brunswick, N.J., pleaded guilty Monday in federal court in Trenton to charges that he got rich by using advance knowledge of the company's pending acquisition on Amylin in 2012.
Read more
2019-12-17 (inquirer.com)
Philly connection to guilty plea by Bristol-Myers Squibb executive on insider trading charges
Former Bristol-Myers Squibb executive Robert Ramnarine of East Brunswick, N.J., pleaded guilty Monday in federal court in Trenton to charges that he got rich by using advance knowledge of the company's pending acquisition on Amylin in 2012.
Read more